ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 160.68 | 45.79 | 32.48 | – | – | – | – | – | 0.00 | 0.00 | 18.61 | 0.00 | |
| – | 108.10 | 40.45 | 3.45 | 2.93 | 6.46 | 6.26 | 6.04 | 3.53 | – | – | – | |
| – | -62.32 | -7.97 | -3.45 | -2.93 | -6.46 | -6.26 | -6.04 | -3.53 | – | 18.61 | – | |
| 5,364.65 | 2,789.03 | 904.98 | 1,450.00 | 277.93 | 298.73 | 159.99 | 144.01 | 120.48 | 36.79 | 10.47 | 2.72 | |
| – | – | – | – | – | – | – | – | 54.29 | 37.19 | 15.36 | 3.01 | |
| 10,721.27 | 4,616.52 | 1,600.54 | 1,799.54 | 634.23 | 577.94 | 316.54 | 260.29 | 171.24 | 73.98 | 25.83 | 5.74 | |
| -11,122.42 | -4,678.84 | -1,608.50 | -1,802.99 | -637.16 | -584.40 | -322.80 | -266.33 | -174.77 | -73.98 | -7.22 | -5.74 | |
| 137.59 | 1.69 | – | 59.07 | 0.09 | 18.68 | 15.45 | 7.92 | 9.90 | 4.93 | 3.35 | 0.93 | |
| -14,823.22 | -11,027.95 | -3,875.24 | -1,875.85 | -638.41 | -588.09 | -379.16 | -419.65 | -183.52 | -72.98 | -9.20 | -5.34 | |
| – | – | -294.50 | – | 1.65 | – | – | – | -0.39 | – | – | – | |
| -14,823.22 | -11,027.95 | -3,580.74 | -1,875.85 | -640.07 | -588.09 | -379.16 | -419.65 | -183.13 | -72.98 | -9.20 | -5.34 | |
| -10,560.59 | -4,570.73 | -1,568.05 | -1,799.54 | -634.23 | -577.94 | -316.54 | -405.70 | -170.10 | -64.59 | -5.37 | -4.41 |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.